DPHA — Disruptive Pharma AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK21.98m
- -SEK12.12m
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover
Brief: Guard Therapeutics Loss Before And After Tax SEK 6.4 Mln
Brief: Guard Therapeutics Updates On Strategic Review
Brief: Guard Therapeutics International Net Sales SEK 0 Thousand
Brief: Guard Therapeutics International Updates On Strategic Review
Brief: Guard Therapeutics Partners In EU Consortium For Alport Syndrome
Brief: Guard Therapeutics Explores Strategic Alternatives
Brief: Guard Therapeutics To Discontinue Development Of RMC-035
Brief: Guard Therapeutics Q3 Loss SEK 26.1 Mln
Brief: Guard Therapeutics International Q2 Loss Up To SEK 32.2 Mln
Brief: Guard Therapeutics International Q1 Loss Pre And After Tax At SEK 34.22 Mln
Brief: Guard Therapeutics Q4 Loss SEK 26 Mln
Brief: Guard Therapeutics International Announces Rights Issue Of About SEK 150 Mln
Brief: Guard Therapeutics Q3 Loss SEK 31.7 Mln
Brief: Guard Therapeutics To Get About SEK 7.2 Mln Through Rights Issue
Brief: Guard Therapeutics Carries Out Announced Rights Issue (Repair Issue)